Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Care | Research article

The longitudinal association between the use of antihypertensive medications and 24-hour sleep in nursing homes: results from the randomized controlled COSMOS trial

Authors: Elisabeth Flo-Groeneboom, Tony Elvegaard, Christine Gulla, Bettina S Husebo

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

Antihypertensive medication use and sleep problems are highly prevalent in nursing home patients. While it is hypothesized that blood pressure and antihypertensive medication use can affect sleep, this has not been investigated in depth in this population. Alongside a multicomponent intervention including a systematic medication review, we aimed to investigate the longitudinal association between antihypertensive medication use, blood pressure and day- and night-time sleep over 4 months.

Methods

This study was based on secondary analyses from the multicomponent cluster randomized controlled COSMOS trial, in which the acronym denotes the intervention: COmmuncation, Systematic pain assessment and treatment, Medication review, Organization of activities and Safety. We included baseline and 4-month follow-up data from a subgroup of nursing home patients who wore actigraphs (n = 107). The subgroup had different levels of blood pressure, from low (< 120) to high (≥ 141). Assessments included blood pressure, antihypertensive medication use, and sleep parameters as assessed by actigraphy.

Results

We found a significant reduction in total sleep time at month four in the intervention group compared to the control group. When analysing the control group alone, we found a significant association between antihypertensive medication use and increased daytime sleep. We also found negative associations between blood pressure, antihypertensive medication use and sleep onset latency in the control group.

Conclusions

Our results suggest a correlation between excessive daytime sleep and antihypertensive medication use. These findings should be followed up with further research, and with clinical caution, as antihypertensive medications are frequently used in nursing homes, and sleep problems may be especially detrimental for this population.

Trial registration

The trial is registered at clinicaltrials.gov (NCT02238652).
Literature
1.
go back to reference Bliwise DL. Sleep disorders in Alzheimer’s disease and other dementias. Clin Cornerstone. 2004;6(1):16–28.CrossRef Bliwise DL. Sleep disorders in Alzheimer’s disease and other dementias. Clin Cornerstone. 2004;6(1):16–28.CrossRef
2.
go back to reference Fetveit A, Bjorvatn B. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study. Am J Geriatr Psychiatry. 2005;13(5):420–3.CrossRef Fetveit A, Bjorvatn B. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study. Am J Geriatr Psychiatry. 2005;13(5):420–3.CrossRef
3.
go back to reference Jacobs D, Ancoli-Israel S, Parker L, Kripke DF. Twenty-four-hour sleep-wake patterns in a nursing home population. Psychol Aging. 1989;4(3):352.CrossRef Jacobs D, Ancoli-Israel S, Parker L, Kripke DF. Twenty-four-hour sleep-wake patterns in a nursing home population. Psychol Aging. 1989;4(3):352.CrossRef
4.
go back to reference Fetveit A, Bjorvatn B. Sleep duration during the 24-hour day is associated with the severity of dementia in nursing home patients. Int J Geriatr Psychiatry. 2006;21(10):945–50.CrossRef Fetveit A, Bjorvatn B. Sleep duration during the 24-hour day is associated with the severity of dementia in nursing home patients. Int J Geriatr Psychiatry. 2006;21(10):945–50.CrossRef
5.
go back to reference Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R, Gladman JR. Health status of UK care home residents: a cohort study. Age Ageing. 2014;43(1):97–103.CrossRef Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R, Gladman JR. Health status of UK care home residents: a cohort study. Age Ageing. 2014;43(1):97–103.CrossRef
6.
go back to reference Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.CrossRef Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.CrossRef
7.
go back to reference Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366–72.CrossRef Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366–72.CrossRef
8.
go back to reference Supiano MA, Williamson JD. Applying the Systolic Blood Pressure Intervention Trial Results to Older Adults. J Am Geriatr Soc. 2017;65(1):16–21.CrossRef Supiano MA, Williamson JD. Applying the Systolic Blood Pressure Intervention Trial Results to Older Adults. J Am Geriatr Soc. 2017;65(1):16–21.CrossRef
9.
go back to reference McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The Burden of Polypharmacy in Patients Near the End of Life. J Pain Symptom Manage. 2016;51(2):178 – 83.e2.CrossRef McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The Burden of Polypharmacy in Patients Near the End of Life. J Pain Symptom Manage. 2016;51(2):178 – 83.e2.CrossRef
10.
go back to reference Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRef Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRef
11.
go back to reference Harrison JK, Van Der Wardt V, Conroy SP, Stott DJ, Dening T, Gordon AL, et al. New horizons: the management of hypertension in people with dementia. Age Ageing. 2016;45(6):740–6.CrossRef Harrison JK, Van Der Wardt V, Conroy SP, Stott DJ, Dening T, Gordon AL, et al. New horizons: the management of hypertension in people with dementia. Age Ageing. 2016;45(6):740–6.CrossRef
12.
go back to reference Betts T, Alford C. β-Blocking Drugs and Sleep A Controlled Trial. Drugs. 1983;25(2):268–72.CrossRef Betts T, Alford C. β-Blocking Drugs and Sleep A Controlled Trial. Drugs. 1983;25(2):268–72.CrossRef
13.
go back to reference Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand. 1987;221(5):475–81.CrossRef Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand. 1987;221(5):475–81.CrossRef
14.
go back to reference Nicholson AN, Roberts DP, Stone BM, Turner C. Antihypertensive therapy in critical occupations: studies with an angiotensin II antagonist. Aviat Space Environ Med. 2001;72(12):1096–101.PubMed Nicholson AN, Roberts DP, Stone BM, Turner C. Antihypertensive therapy in critical occupations: studies with an angiotensin II antagonist. Aviat Space Environ Med. 2001;72(12):1096–101.PubMed
15.
go back to reference van der Wardt V, Logan P, Conroy S, Harwood R, Gladman J. Antihypertensive Treatment in People With Dementia. J Am Med Dir Assoc. 2014;15(9):620–9.CrossRef van der Wardt V, Logan P, Conroy S, Harwood R, Gladman J. Antihypertensive Treatment in People With Dementia. J Am Med Dir Assoc. 2014;15(9):620–9.CrossRef
16.
go back to reference Zuurbier LA, Luik AI, Leening MJ, Hofman A, Freak-Poli R, Franco OH, et al. Associations of heart failure with sleep quality: the Rotterdam Study. J Clin Sleep Med. 2015;11(2):117–21.CrossRef Zuurbier LA, Luik AI, Leening MJ, Hofman A, Freak-Poli R, Franco OH, et al. Associations of heart failure with sleep quality: the Rotterdam Study. J Clin Sleep Med. 2015;11(2):117–21.CrossRef
17.
go back to reference Eshkoor SA, Hamid TA, Nudin SS, Mun CY. Importance of hypertension and social isolation in causing sleep disruption in dementia. Am J Alzheimer’s Dis Other dement. 2014;29(1):61–6.CrossRef Eshkoor SA, Hamid TA, Nudin SS, Mun CY. Importance of hypertension and social isolation in causing sleep disruption in dementia. Am J Alzheimer’s Dis Other dement. 2014;29(1):61–6.CrossRef
18.
go back to reference Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc. 2000;48(10):1234–40.CrossRef Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc. 2000;48(10):1234–40.CrossRef
19.
go back to reference Suzuki R, Meguro M, Meguro K. Sleep disturbance is associated with decreased daily activity and impaired nocturnal reduction of blood pressure in dementia patients. Arch Gerontol Geriatr. 2011;53(3):323–7.CrossRef Suzuki R, Meguro M, Meguro K. Sleep disturbance is associated with decreased daily activity and impaired nocturnal reduction of blood pressure in dementia patients. Arch Gerontol Geriatr. 2011;53(3):323–7.CrossRef
20.
go back to reference Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska LS, Miller MH. CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology. 1990;102(2):163–70.CrossRef Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska LS, Miller MH. CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology. 1990;102(2):163–70.CrossRef
21.
go back to reference Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255–73.CrossRef Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255–73.CrossRef
22.
go back to reference Flo E, Bjorvatn B, Corbett A, Pallesen S, Husebo BS. Joint occurrence of pain and sleep disturbances in people with dementia. A systematic review. Curr Alzheimers Res. 2016;14:538–45. Flo E, Bjorvatn B, Corbett A, Pallesen S, Husebo BS. Joint occurrence of pain and sleep disturbances in people with dementia. A systematic review. Curr Alzheimers Res. 2016;14:538–45.
23.
go back to reference Parati G, Lombardi C, Castagna F, Mattaliano P, Filardi PP, Agostoni P. Heart failure and sleep disorders. Nat Rev Cardiol. 2016;13(7):389–403.CrossRef Parati G, Lombardi C, Castagna F, Mattaliano P, Filardi PP, Agostoni P. Heart failure and sleep disorders. Nat Rev Cardiol. 2016;13(7):389–403.CrossRef
24.
go back to reference Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22(Suppl 2):366-72. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22(Suppl 2):366-72.
25.
go back to reference Vargas I, Nguyen AM, Muench A, Bastien CH, Ellis JG, Perlis ML. Acute and Chronic Insomnia: What Has Time and/or Hyperarousal Got to Do with It? Brain Sciences. 2020;10(2):71.CrossRef Vargas I, Nguyen AM, Muench A, Bastien CH, Ellis JG, Perlis ML. Acute and Chronic Insomnia: What Has Time and/or Hyperarousal Got to Do with It? Brain Sciences. 2020;10(2):71.CrossRef
26.
go back to reference Li Y, Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Sun Y, Zhou J, et al. Insomnia with physiological hyperarousal is associated with hypertension. Hypertension. 2015;65(3):644–50.CrossRef Li Y, Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Sun Y, Zhou J, et al. Insomnia with physiological hyperarousal is associated with hypertension. Hypertension. 2015;65(3):644–50.CrossRef
27.
go back to reference Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–402.CrossRef Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–402.CrossRef
28.
go back to reference Gulla C, Flo E, Kjome RL, Husebo BS. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. Journal of geriatric cardiology: JGC. 2018;15(4):275–83.PubMedPubMedCentral Gulla C, Flo E, Kjome RL, Husebo BS. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. Journal of geriatric cardiology: JGC. 2018;15(4):275–83.PubMedPubMedCentral
29.
go back to reference Husebo BS, Ballard C, Aarsland D, Gulla C, Aasmul I, Elvegaard T, et al. The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS). J Am Med Direct Assoc. 2018;20(3):330–9. Husebo BS, Ballard C, Aarsland D, Gulla C, Aasmul I, Elvegaard T, et al. The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS). J Am Med Direct Assoc. 2018;20(3):330–9.
30.
go back to reference Husebo BS, Flo E, Aarsland D, Selbaek G, Testad I, Gulla C, et al. COSMOS–improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial. Implement Sci. 2015;10(1):131.CrossRef Husebo BS, Flo E, Aarsland D, Selbaek G, Testad I, Gulla C, et al. COSMOS–improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial. Implement Sci. 2015;10(1):131.CrossRef
31.
go back to reference Aasmul I, Husebo BS, Flo E. Description of an advance care planning intervention in nursing homes: outcomes of the process evaluation. BMC Geriatr. 2018;18(1):26.CrossRef Aasmul I, Husebo BS, Flo E. Description of an advance care planning intervention in nursing homes: outcomes of the process evaluation. BMC Geriatr. 2018;18(1):26.CrossRef
32.
go back to reference Aasmul I, Husebo BS, Sampson EL, Flo E. Advance Care Planning in Nursing homes–Improving the Communication between Patient, Family and Staff: Results from a Cluster. Randomized Controlled Trial. Front Psychol. 2018;9:2284. Aasmul I, Husebo BS, Sampson EL, Flo E. Advance Care Planning in Nursing homes–Improving the Communication between Patient, Family and Staff: Results from a Cluster. Randomized Controlled Trial. Front Psychol. 2018;9:2284.
33.
go back to reference de Jong-Schmit BEM, Poortvliet RKE, Böhringer S, Bogaerts JMK, Achterberg WP, Husebo BS. Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study. Int J Geriatr Psychiatry. 2021;36(1):e5388.CrossRef de Jong-Schmit BEM, Poortvliet RKE, Böhringer S, Bogaerts JMK, Achterberg WP, Husebo BS. Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study. Int J Geriatr Psychiatry. 2021;36(1):e5388.CrossRef
35.
go back to reference Guidelines for medication reviews. Norwegian Directorate of Health. Oslo, Norway: Norwegian Directorate of Health; 2012. Guidelines for medication reviews. Norwegian Directorate of Health. Oslo, Norway: Norwegian Directorate of Health; 2012.
36.
go back to reference Agency NM. Check list for medication review. 2014. Agency NM. Check list for medication review. 2014.
37.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef
38.
go back to reference Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485–96.CrossRef Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485–96.CrossRef
39.
go back to reference Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One. 2012;7(6):e39198.CrossRef Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One. 2012;7(6):e39198.CrossRef
40.
go back to reference Lambiase MJ, Gabriel KP, Chang YF, Kuller LH, Matthews KA. Utility of actiwatch sleep monitor to assess waking movement behavior in older women. Med Sci sports Exerc. 2014;46(12):2301–7.CrossRef Lambiase MJ, Gabriel KP, Chang YF, Kuller LH, Matthews KA. Utility of actiwatch sleep monitor to assess waking movement behavior in older women. Med Sci sports Exerc. 2014;46(12):2301–7.CrossRef
42.
go back to reference Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: Practical method for grading cognitive state of patients for clinician. J Psychiatr Res. 1975;12:189–98.CrossRef Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: Practical method for grading cognitive state of patients for clinician. J Psychiatr Res. 1975;12:189–98.CrossRef
43.
go back to reference Lawton MP, Brody EM. Assessment of Older People - Self-Maintaining and Instrumental Activities of Daily Living. Gerontologist. 1969;9:179–8.CrossRef Lawton MP, Brody EM. Assessment of Older People - Self-Maintaining and Instrumental Activities of Daily Living. Gerontologist. 1969;9:179–8.CrossRef
44.
go back to reference Cooke JR, Ancoli-Israel S Normal and Abnormal Sleep in the Elderly. Handbook of clinical neurology / edited by PJ Vinken and GW Bruyn. 2011;98:653 – 65. Cooke JR, Ancoli-Israel S Normal and Abnormal Sleep in the Elderly. Handbook of clinical neurology / edited by PJ Vinken and GW Bruyn. 2011;98:653 – 65.
45.
go back to reference Gulla C, Flo E, Kjome RLS, Husebo BS. Implementing a novel strategy for interprofessional medication review using collegial mentoring and systematic clinical evaluation in nursing homes (COSMOS). BMC Geriatr. 2019;19(1):130.CrossRef Gulla C, Flo E, Kjome RLS, Husebo BS. Implementing a novel strategy for interprofessional medication review using collegial mentoring and systematic clinical evaluation in nursing homes (COSMOS). BMC Geriatr. 2019;19(1):130.CrossRef
Metadata
Title
The longitudinal association between the use of antihypertensive medications and 24-hour sleep in nursing homes: results from the randomized controlled COSMOS trial
Authors
Elisabeth Flo-Groeneboom
Tony Elvegaard
Christine Gulla
Bettina S Husebo
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Care
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02317-4

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.